Share on StockTwits

Response Genetics (NASDAQ:RGDX) posted its quarterly earnings results on Thursday. The company reported ($0.08) earnings per share for the quarter, Stock Ratings reports. The company had revenue of $4.30 million for the quarter, compared to the consensus estimate of $3.90 million.

Shares of Response Genetics (NASDAQ:RGDX) opened at 0.6701 on Thursday. Response Genetics has a 1-year low of $0.61 and a 1-year high of $2.93. The stock’s 50-day moving average is $0.81 and its 200-day moving average is $1.09. The company’s market cap is $26.0 million.

Response Genetics, Inc focuses on providing molecular profiling services of tumor tissue that has been formalin-fixed and embedded in paraffin wax.

Receive News & Ratings for Response Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Response Genetics and related companies with Analyst Ratings Network's FREE daily email newsletter.